Association of Antibiotic Utilization Measures and Control of Extended-spectrum-lactamases (ESBLs).
Phase of Trial: Phase IV
Latest Information Update: 14 Apr 2011
At a glance
- Drugs Piperacillin/tazobactam (Primary)
- Indications Escherichia coli infections; Klebsiella infections
- Focus Therapeutic Use
- Sponsors Wyeth
- 21 Jun 2010 Actual end date (Mar 2005) added as reported by ClinicalTrials.gov.
- 21 Jun 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 30 Oct 2006 New trial record.